By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

PDS Biotechnology Corporation 



Indianapolis  Indiana    U.S.A.
Phone: 513-475-6610 Fax: 513-221-1891


SEARCH JOBS








Company News
PDS Biotechnology Corporation Announces Appointment Of Biotech Industry Leader Sir Richard Sykes To Its Board Of Directors As Executive Chairman 12/18/2014 9:17:16 AM
NetScientific Invests In Next Generation, Immunotherapeutics Company, PDS Biotechnology Corporation 12/15/2014 8:53:15 AM
PDS Biotechnology Corporation Announces Treatment Of First Patient With PDS0101 Based On The Novel Versamune™ Cancer Immunotherapy Platform In A Phase 1 Clinical Trial 2/11/2014 10:02:51 AM
PDS Biotechnology Corporation Signs Worldwide Licensing Agreement With Merck KGaA (MKGAF.PK) for Versamuneā„¢ 7/9/2012 7:35:43 AM
PDS Biotechnology Corporation Awarded $1.28M National Cancer Institute Contract 3/2/2010 8:53:57 AM
PDS Biotechnology Corporation Demonstrates Pre-Clinical Safety of its Versamune(TM)-Based HPV Product 10/6/2009 8:54:32 AM
PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG 2/24/2009 11:00:18 AM
PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies 11/7/2008 7:41:08 AM
//-->